Ballentine Partners’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
4,820
+383
+9% +$21.9K ﹤0.01% 887
2026
Q1
$263K Buy
+4,437
New +$214K ﹤0.01% 803
2024
Q3
Sell
-4,503
Closed -$211K 873
2024
Q2
$211K Buy
4,503
+402
+10% +$20.2K ﹤0.01% 682
2024
Q1
$213K Buy
+4,101
New +$187K ﹤0.01% 652
2023
Q1
Sell
-4,844
Closed -$246K 587
2022
Q4
$246K Buy
4,844
+38
+0.8% +$1.99K 0.01% 424
2022
Q3
$221K Buy
+4,806
New +$230K 0.01% 416
2022
Q2
Sell
-4,532
Closed -$245K 469
2022
Q1
$245K Buy
+4,532
New +$195K 0.01% 402

Other funds holding OVV

Ballentine Partners's OVV Position: Q2 2026 in Review

Ballentine Partners increased its Ovintiv (OVV) stake by 8.6% in Q2 2026, buying an estimated $21.9K and bringing the position to 4,820 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Ballentine Partners first reported a position in OVV in Q1 2022 and has held it in 7 quarters since. The position peaked at $263K in Q1 2026. 101 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • Ballentine Partners held 4,820 shares of Ovintiv worth $254K as of Q2 2026.
  • Ballentine Partners bought 383 Ovintiv shares in Q2 2026, an estimated $21.9K.
  • Ovintiv made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #887 holding.
  • Ballentine Partners first reported a position in Ovintiv in Q1 2022 and has held it in 7 quarters since.
  • Ballentine Partners's Ovintiv position peaked at $263K in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.